Key takeaways and insights
From innovation to faster patient access, DIA Europe 2026 spotlighted priorities to help Europe remain a global life sciences leader. These include modernized, agile regulation (EU pharma legislation, EU Biotech Act), earlier patient involvement, better data sharing, and smarter global trial approaches. AI was everywhere, but practical use cases and assurance around privacy, bias, and explainability remain key.
Driving innovation, improving access, and the potential for AI: DIA Europe takeaways
DIA Europe 2026 brought together stakeholders from across the life sciences community to explore issues that are top of mind for industry – from bolstering innovation in Europe to improving patient access to streamlining processes and supporting regulatory rigor, including through the adoption of digital technologies.
Navigate Regulatory Complexities With Ease
Regulatory & CMC Services
Bring your product to market faster — with confidence. Our global Regulatory Affairs and CMC experts support you at every stage of development, submission, launch, and lifecycle management. Backed by scientific depth, local‑market insight, and seamless operational delivery, we help you accelerate approvals, stay compliant, and expand globally.
Why partner with Cencora:
Our core services:
Why partner with Cencora:
- Faster, smoother launches to get products approved, stay on the market, and grow globally.
- Proactive change management through globally distributed teams with strong local expertise.
- A true extension of your organization, offering flexible regional and local delivery models.
Our core services:
- Health authority advisory
- Regulatory strategy & consulting
- CMC services
- Clinical trial authorization applications
- Marketing authorization applications & procedure management
- Product information & readability services
- Regulatory informatics & operations
- Lifecycle management & post‑approval support
Related Resources
Article
Forging ahead with US and EU healthcare policy changes
Health care is at an inflection point in the US and Europe, marked by the introduction of new policies aimed at maintaining the sustainability of healthcare systems whilst balancing innovation and ensuring patient access to essential medications.
Connect with our team
Our team of leading value experts is dedicated to transforming evidence, policy insights, and market intelligence into effective global market access strategies. Let us help you navigate today’s complex healthcare landscape with confidence. Reach out to discover how we can support your goals.
